---
$id: https://graph.org.ai/products/commodity/51282322
$type: Product
source: UNSPSC
code: "51282322"
title: "Erythromycin lactobionate"
class: "51282300"
classTitle: "Erythromycins"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Erythromycin lactobionate

**UNSPSC Code**: 51282322
**Class**: [Erythromycins](Erythromycins.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a macrolide antibiotic with the molecular formula C37H67NO13.C12H22O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 33H58I7GLQ, chemically known as erythromycin, n-demethyl-n-(methyl-11c)- but more generally known as erythromycin lactobionate, which bears US NIH Compound Identifier 12560. European Medicines Agency schedules Erythromycin lactobionate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01944MIG. Most nations, for tariff and trade purposes, schedule erythromycin lactobionate under HS 29415000 and SITC 54139. Erythromycin lactobionate bears US NLM identifiers UMLS ID C0059562 and NCI Concept Code C47988. SMILES: As of Q4 2014, ERYTHROMYCIN LACTOBIONATE remains US FDA's Preferred Term for this commodity.

